Viewing Study NCT06392776



Ignite Creation Date: 2024-05-06 @ 8:27 PM
Last Modification Date: 2024-10-26 @ 3:28 PM
Study NCT ID: NCT06392776
Status: RECRUITING
Last Update Posted: 2024-05-30
First Post: 2024-04-26

Brief Title: Early Diagnosis and Treatment of Undiagnosed Asthma or COPD THE UCAP 2 TRIAL
Sponsor: Ottawa Hospital Research Institute
Organization: Ottawa Hospital Research Institute

Study Overview

Official Title: Early Diagnosis and Treatment of Undiagnosed Asthma or COPD THE UCAP 2 TRIAL
Status: RECRUITING
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: UCAP2
Brief Summary: Our research group has found that Canadians with undiagnosed asthma or chronic obstructive pulmonary disease COPD have increased respiratory symptoms and worse health-related quality of life

The investigators recently developed and validated an on-line questionnaire to accurately identify these symptomatic undiagnosed individuals

The investigators will advertise in the community asking individuals to complete the on-line questionnaire at home at their leisure to determine if they are at risk of asthma or COPD Those at risk will be invited to participate in a randomized controlled clinical trial to determine whether early diagnosis of previously undiagnosed asthma or COPD and subsequent treatment by the primary care practitioner will improve their quality of life
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None